We are live on ! Find out more
USNA icon

Usana Health Sciences

162 hedge funds and large institutions have $290M invested in Usana Health Sciences in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

26% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 47

12% more call options, than puts

Call options by funds: $232K | Put options by funds: $207K

7% more funds holding

Funds holding: 152162 (+10)

0.29% more ownership

Funds ownership: 56.57%56.86% (+0.29%)

25% less capital invested

Capital invested by funds: $387M → $290M (-$97M)

Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
2.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
59
Reduced
47
Closed
21
Calls
$232K
Puts
$207K
Net Calls
+$25K
Net Calls Change
+$57K

USNA Hedge Fund Activity: Q1 2025 in Review

162 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2025, worth a combined $290M — down 25% from $387M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new USNA positions and 21 closed out — a net gain of 10 holders — while 59 added to existing stakes and 47 trimmed.

The largest buyer was Millennium Management, adding an estimated $3.55M. The largest seller was Pacer Advisors, cutting an estimated $14.7M.

  • 162 institutional investors held Usana Health Sciences (USNA) as of Q1 2025, up from 152 in Q4 2024.
  • Funds reported $290M of Usana Health Sciences stock for Q1 2025, down 25% quarter-over-quarter.
  • 31 funds opened new Usana Health Sciences positions in Q1 2025 and 21 closed out, a net change of +10 holders.
  • The largest Usana Health Sciences buyer in Q1 2025 was Millennium Management, an estimated $3.55M added.
  • The largest Usana Health Sciences seller in Q1 2025 was Pacer Advisors, an estimated $14.7M sold.

Based on aggregated 13F filings for Q1 2025.